Sandro C. Esteves, MD., PhD.
Director, ANDROFERT
Andrology & Human Reproduction Clinic
Campinas, BRAZIL
Medical Management of
Male Infertility
Reproductive Andrology Surgery Workshop 2014 
Al Jahra Hospital, KUWAIT
ISO 9001:2008
Available at:

h"p://www.androfert.com.br/review	
  
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 2
2014 APRIL
ANDROFERT
Medical Management of
Male Infertility
Lecture	
  Outline	
  
Overview 
Empiric Tx of idiopathic oligozoospermia 
Specific Tx for subclinical MAGI
Hormonal Tx for hypo-hypo
Aromatase inhibitors in obese-related male
infertility
Antioxidants for oxidative-stress alleviation 
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 3
2014 APRIL
ANDROFERT
Empirical medical Tx of
idiopathic oligozoospermia
Guidelines on Male Infertility.
European Association of Urology 2012	
  
In	
  general,	
  
NOT	
  
EFFECTIVE	
  
Androgens
hCG/HMG/FSH
Aromatase inhibitors
Anti-estrogens
Bromocriptine
Alpha-blockers
Systemic corticosteroids 
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 4
2014 APRIL
ANDROFERT
Injectable testosteroned	
  
GnRH
FSH/LH
Azoospermia
Marked fall in ITT levels
Between the seminiferous
tubules, Leydig cells produce
testosterone
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 5
2014 APRIL
ANDROFERT
Who benefit from medical Tx? 



Estradiol 
levels
FSH & LH
levels
Total
Testosterone
levels
<300
ng/dL
(10.4 nmol/L)
Normal/
Elevated
T/E ratio
<10
<1.2 mUI/
mL
Hypogonadism
category
T/E ratio
>10 (nl)
Hypo-
hypo
Aromatase
hyperactivity
Pure
Treatment
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 6
2014 APRIL
ANDROFERT
Deficient virilization; Hypotrophic testes 
Azoospermia
Low FSH and LH (<1.2 mIU/L)
Low total testosterone (<300 ng/dL)

Hypogonadotropic hypogonadism
Specific medical therapy
• Congenital:
Kallman syndrome
Prader-Willi 
• Acquired:
Pituitary tumor
Steroid abuse
Testosterone replacement therapy
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 7
2014 APRIL
ANDROFERT
Classic treatment for male
hypogonadism and infertility
Urinary hCG 1,000-2,000 UI IM
injections; twice or t.i.w;
minimum 12 weeks
Rec-hCG: SC self-
injection w/pre-filled
syringe, qw
Fraietta & Esteves Clinics 2013
Adult onset hypo- hypo 
Specific medical therapy
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 8
2014 APRIL
ANDROFERT
Rec-hCG for male hypo-hypo
Baseline
 Posttreatment
 Esteves & Papanikolaou Fertil Steril 2011
Series of men with adult-onset HH; 
Recombinant hCG (Ovitrelle 250 mcg)
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 9
2014 APRIL
ANDROFERT
Who benefit from medical Tx? 
Total
Testosterone
levels
<300ng/dL
(10.4 nmol/L)
FSH & LH
levels
Normal/
Elevated
<1.2 mUI/
mL



Estradiol 
levels
T/E ratio
<10
T/E ratio
>10 (nl)
Hypogonadism
category
Hypo-
hypo
Aromatase
hyperactivity
Pure
Treatment
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 10
2014 APRIL
ANDROFERT
Estradiol levels in obese men is
modulated by aromatase polymorphism


Aromatase is a
product of the CYP19
gene
Most common
polymorphism is
tetranucleotide repeat
(TTTAn) 
Higher TTTAn (X-X)
repeat associated with
increased E2 levels
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 12
2014 APRIL
ANDROFERT
Oligozoospermia in obese men
Risk of Oligozoospermia:

Overweight*: OR=1.28 

 
(95% CI: 1.06-1.55)

(95% CI: 1.59-2.62)
*BMI greater than or equal to 25; **BMI greater than or equal to 30; 
Sermondade et al. Hum Reprod Update. 2013 
Meta-analysis of 21 studies; 13,077 men
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 13
2014 APRIL
ANDROFERT
Obesity in men at reproductive age
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 14
2014 APRIL
ANDROFERT
Total Testosterone (ng/dL) and
Estradiol (pg/mL) Levels
T/E2 Ratio
 Normal > 10
Zumoff et al. Metabolism 2003;
Raman & Schlegel J Urol 2002
T/E2 <10
Aromatase Hyperactivity
Aromatase inhibitors in obese-
related oligozoospermia
Anastrozole 1 mg
q1d 60 days
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 15
2014 APRIL
ANDROFERT
Raman & Schlegel. J Urol. 2002
5.9
2.9
5.5
15.6
3.5
15.6
0
5
10
15
20
T/E ratio Ejaculate volume
(mL)
Sperm Count
(million/mL)
Anastrazole (1mg q1d for 3-6 months)
in Oligozoospermia
Pre-treatment Post-treatment
Aromatase Inhibitors for 
Obesity-related Male Infertility
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 16
2014 APRIL
ANDROFERT
Who benefit from medical Tx? 



Estradiol 
levels
FSH & LH
levels
Total
Testosterone
levels
<300ng/
dL
Normal/
Elevated
T/E ratio
<10
<1.2 mUI/
mL
Hypogonadism
category
T/E ratio
>10 (nl)
Hypo-
hypo
Aromatase
hyperactivity
Pure
Treatment
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 17
2014 APRIL
ANDROFERT
Pure hypogonadism
ART Candidates
Severe oligozoospermia
Non-obstructive azoospermia 


Options
Anti-estrogens
u-hCG/rec-hCG


ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 18
2014 APRIL
ANDROFERT
Ramasamy et al., J Urol. 2009 
Ø  68 men with non-mosaic KS
Ø  Non-obstructive azoospermia and
hypogonadism
Ø  ART candidates
Ø  Medication to boost testosterone
production: Aromatase inhibitor,
hCG, anti-estrogens (2-3 months)
Ø  Micro-TESE as SR method
Ø  Positive response: increase in TT
>100 ng/dL from baseline levels
72
55
Sperm Retrieval Rate (%)
Positive response
P	
  =	
  0.03	
  

Medication before sperm retrieval in 
Klinefelter syndrome men (47,XXY)
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 19
2014 APRIL
ANDROFERT
51	
   51	
  
Sperm retrieval rate (%)
Positive response (n=252)
No response (n=55)
Ø  Case series (n=307): unselected
group of men with testicular failure
and low testosterone levels 

(300 nd/dL)
Ø  Micro-TESE
Ø  Medication to boost testosterone
production: Aromatase inhibitor,
hCG, anti-estrogens (min. 2-3
months)
Ø  Positive response: posttreatment
TT >250 ng/dL
Medication prior to SR in
unselected men with NOA
Ramasamy et al., J Urol. 2011 
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 20
2014 APRIL
ANDROFERT
800	
  
Before
Clomiphene
After
90d; 25mg/d

Da Ros CT, Averbeck MA 
Int Braz J Urol 2012
Anti-estrogens in Hypogonadism
1000	
  
1200	
  
1400	
  
600	
  
400	
  
200	
  
0	
  
ng/dL
Upper Limit
Lower Limit
Lower
Sperm
Counts
ITT levels
fall
Normal Testosterone
Levels
Negative
central
feedback
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 21
2014 APRIL
ANDROFERT
Medical Tx - Key Messages (1)
Empirical medication for idiopathic
oligozoospermia not recommended
Infertile males with hypogonadism
(TT<300) candidates for Tx
hCG is the treatment of choice for
adult-onset hypogonadotropic
hyponadism
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 22
2014 APRIL
ANDROFERT
Medical Tx - Key Messages (2)
Aromatase inhibitors helpful for
overweight/obese men with aromatase
hyperactivity (T/E<10) and
oligozoospermia
hCG/anti-estrogens helpful to boost
testosterone production (sperm
production?) in selected ART candidates 
Minimum Tx duration 8 weeks; monitor TT
levels regularly to dose titration
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 23
2014 APRIL
ANDROFERT
Lecture	
  Outline	
  
Overview 
Empiric Tx of idiopathic oligozoospermia 
Specific Tx for subclinical MAGI
Hormonal Tx for hypo-hypo
Aromatase inhibitors in obese-related male
infertility
Antioxidants for oxidative-stress alleviation 
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 24
2014 APRIL
ANDROFERT
Subclinical Male Genital Tract
Infection 
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 25
2014 APRIL
ANDROFERT
Urethritis, prostatitis
AnN-­‐bacterial	
  
properNes	
  (Zinc)	
  
Yanushpolsky et al 1996, 
Saleh & Agarwal 2002, 
Aziz et al 2004 
Leukocytospermia
>1.0 x 106 leukocytes per mL of semen
marker of reproductive
tract inflammation
MacrophageNeutrophils
Subclinical Male Genital Tract
Infection (MAGI)
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 26
2014 APRIL
ANDROFERT
25%	
  
34%	
  
39%	
  
Normal Abnormal Abnl &
Leukocytospermia
% DNA Damage (SCSA)
Seminal Leukocytes

 
 
 
Endtz Test 
Simple diagnostic method



Peroxidase-negative
Peroxidase-positive
Granulocytes (Neutrophils)
substrate
+
H2O2
+
semen
Esteves et al. CLINICS 2011; 66:1-10.
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 27
2014 APRIL
ANDROFERT
•  Yanushpolsky et al, 1995; Erel et al., 1997
•  Branigan et al., 1995
Antibiotics
•  Lackner et al., 2006
•  Gambera et al., 2007
Cicloxigenase-2
Inhibitors
•  Oliva & Mutigner, 2006
Antihistamines
•  Tremellen et al., 2007
•  Piombini et al., 2008
Antioxidants
Treatment of Subclinical Male Genital
Tract Infection and Associated
Inflammatory Changes
	
  
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 28
2014 APRIL
ANDROFERT
Subclinical Male Genital Tract
Infection 
Azitromycin 1.0g single dose (couple)+ frequent
ejaculation (every 2-3 days) + Antioxidants
42% leukocytospermia resolution (N=278; Androfert)
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 29
2014 APRIL
ANDROFERT
OxidaNve	
  Stress	
  
30%-80% of infertile men
have elevated markers of OS
Agarwal et al., Urology 2006
An	
  emerging	
  
explanaNon	
  for	
  
several	
  cases	
  of	
  
male	
  inferNlity	
  
Oral Antioxidants
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 30
2014 APRIL
ANDROFERT
Chemical species with unpaired
electron capable to oxidize lipids,
proteins and nucleic acids:
Superoxide anion (•O-2)
Hydroxyl radical (•OH)
Hydrogen peroxide (H2O2)
Peroxyl radical (ROO•)
Hypochlorite ion (OCl-)
Generated from aerobic metabolism
of sperm and leukocytes’
mitochondria



Lampiao et al., 2012
Reactive Oxygen Species (ROS)
Sperm and Seminal Plasma Antioxidants:
Enzymatic (SOD, catalase, GPX): inactivate ROS by conversion into
other substances
Non-enzymatic (ascorbic acid, alpha-tocopherol, carnitine, etc.):
neutralize ROS
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 31
2014 APRIL
ANDROFERT
Rationale of Oral
Antioxidants use
OA classified according to
their mechanism of action: 
Catalytic: enhances the
already present antioxidant
enzymes (Glutathione, N-
acetyl-cysteine).
Scavenging:
Water soluble: react with
oxidants in the cytosol
(Vitamin C)
Lipid soluble: protect cell
membrane from lipid
peroxidation (Vitamin E)
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 32
2014 APRIL
ANDROFERT
Outcome
 No. studies
 Effect size 
(OR; 95% CI)
Live birth
 3
 4.85 [1.92, 12.24]
Pregnancy rate 
 15
 4.18 [2.65, 6.59]
DNA fragmentation
 1
 -13.80 [-17.50,
-10.10]
Miscarriage, sperm
count, sperm motility
6-16
 No effect
Oral Antioxidants
Showell MG et al. Cochrane Database Syst Rev 2011
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 33
2014 APRIL
ANDROFERT
Oral Antioxidants
•  Short-term use
appear to be safe
•  Caution against
indiscriminate use
of high dosages
for long periods
Beneficial
Kodama 1997
Dawson, 1992
Kessopoulou, 1995
Vezina, 1996
Vicari, 2001; 2002
Lenzi, 2003; 2004
Cavallini, 2004
Comhaire, 2005
Grecco 2005
Menezo 2007
Tremellen 2007
Piomboni 2008
Gil Villa 2009
No effect
Giovenco, 1987
Moilanen, 1993
Iwanier, 1995
Rolf, 1999
Sigman, 2006
Detrimental
long-term use and high
doses;
increased mortality in
cancer population-
based studies.
Heinonen, 1994
Lonn, 2005
Bjelakovic, 2007
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 34
2014 APRIL
ANDROFERT
How to use Antioxidant Therapy



Ascorbic acid (Vit. C)
α- tocopherol (Vit. E)
Glutathione
N-acetyl-cysteine
Carnitine, Coenzyme Q10
Lycopene. Picnogenol
Pentoxifylline. Selenium
Shao-Fu-Zhu-Yu-Tang
Astaxanthin
Lepidium meyenii
α -linolenic acid and lignans
Folic acid, Zinc
Select antioxidant
formulation and dosage


Testing for
Leukocytes in Semen

Differentiate between
sperm and leukocyte
source of ROS

Varicocele
Genital Infection
Smoking
Medication
Drug abuse
Systemic diseases
Pollution
Radiation
Focus on identifying
and controlling source
of increased ROS
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 35
2014 APRIL
ANDROFERT
Oral Antioxidants
How I prescribe
Vitamin C 500mg; Vitamin E 400 mg
Folic acid 2 mg, Zinc 25 mg
Selenium 26 mcg
Minimum 2 months
Old concept ~80 days
New concept ~60
days
From initiation of sperm production to ejaculation
Misell LM et al. J Urol. 2006
Esteves & Agarwal. Novel concepts in male infertility. Int Braz J Urol 2011
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 36
2014 APRIL
ANDROFERT
Asymptomatic leukocytospermia is mainly
caused by urethritis 
ROS production increase with an increase in
leukocyte numbers
Antibiotic therapy is suggested, but effect on
fertility is still unclear (GR-B)
Medical Tx - Key Messages (3)
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 37
2014 APRIL
ANDROFERT
Oxidative stress impairs sperm function and
is a risk factor for male infertility (GR-A)
OA supplementation for subfertile males
improve the chances of live birth for couples
undergoing ART (GR-A) 
Well-designed studies are needed to
determine the best candidates for OA therapy
and which formulation and dosages yield
better results
Medical Tx - Key Messages (4)
ANDROFERT
androfert.com.br
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 38
2014 APRIL
ANDROFERT
Thank you Obrigado 

‫شكرا‬

Medical Management of Male Factor Infertility

  • 1.
    Sandro C. Esteves,MD., PhD. Director, ANDROFERT Andrology & Human Reproduction Clinic Campinas, BRAZIL Medical Management of Male Infertility Reproductive Andrology Surgery Workshop 2014 Al Jahra Hospital, KUWAIT ISO 9001:2008
  • 2.
    Available at: h"p://www.androfert.com.br/review   ANDROFERT androfert.com.br ANDROLOGYAND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 2 2014 APRIL ANDROFERT Medical Management of Male Infertility
  • 3.
    Lecture  Outline   Overview Empiric Tx of idiopathic oligozoospermia Specific Tx for subclinical MAGI Hormonal Tx for hypo-hypo Aromatase inhibitors in obese-related male infertility Antioxidants for oxidative-stress alleviation ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 3 2014 APRIL ANDROFERT
  • 4.
    Empirical medical Txof idiopathic oligozoospermia Guidelines on Male Infertility. European Association of Urology 2012   In  general,   NOT   EFFECTIVE   Androgens hCG/HMG/FSH Aromatase inhibitors Anti-estrogens Bromocriptine Alpha-blockers Systemic corticosteroids ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 4 2014 APRIL ANDROFERT
  • 5.
    Injectable testosteroned   GnRH FSH/LH Azoospermia Markedfall in ITT levels Between the seminiferous tubules, Leydig cells produce testosterone ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 5 2014 APRIL ANDROFERT
  • 6.
    Who benefit frommedical Tx? Estradiol levels FSH & LH levels Total Testosterone levels <300 ng/dL (10.4 nmol/L) Normal/ Elevated T/E ratio <10 <1.2 mUI/ mL Hypogonadism category T/E ratio >10 (nl) Hypo- hypo Aromatase hyperactivity Pure Treatment ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 6 2014 APRIL ANDROFERT
  • 7.
    Deficient virilization; Hypotrophictestes Azoospermia Low FSH and LH (<1.2 mIU/L) Low total testosterone (<300 ng/dL) Hypogonadotropic hypogonadism Specific medical therapy • Congenital: Kallman syndrome Prader-Willi • Acquired: Pituitary tumor Steroid abuse Testosterone replacement therapy ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 7 2014 APRIL ANDROFERT
  • 8.
    Classic treatment formale hypogonadism and infertility Urinary hCG 1,000-2,000 UI IM injections; twice or t.i.w; minimum 12 weeks Rec-hCG: SC self- injection w/pre-filled syringe, qw Fraietta & Esteves Clinics 2013 Adult onset hypo- hypo Specific medical therapy ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 8 2014 APRIL ANDROFERT
  • 9.
    Rec-hCG for malehypo-hypo Baseline Posttreatment Esteves & Papanikolaou Fertil Steril 2011 Series of men with adult-onset HH; Recombinant hCG (Ovitrelle 250 mcg) ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 9 2014 APRIL ANDROFERT
  • 10.
    Who benefit frommedical Tx? Total Testosterone levels <300ng/dL (10.4 nmol/L) FSH & LH levels Normal/ Elevated <1.2 mUI/ mL Estradiol levels T/E ratio <10 T/E ratio >10 (nl) Hypogonadism category Hypo- hypo Aromatase hyperactivity Pure Treatment ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 10 2014 APRIL ANDROFERT
  • 12.
    Estradiol levels inobese men is modulated by aromatase polymorphism Aromatase is a product of the CYP19 gene Most common polymorphism is tetranucleotide repeat (TTTAn) Higher TTTAn (X-X) repeat associated with increased E2 levels ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 12 2014 APRIL ANDROFERT
  • 13.
    Oligozoospermia in obesemen Risk of Oligozoospermia: Overweight*: OR=1.28 (95% CI: 1.06-1.55) (95% CI: 1.59-2.62) *BMI greater than or equal to 25; **BMI greater than or equal to 30; Sermondade et al. Hum Reprod Update. 2013 Meta-analysis of 21 studies; 13,077 men ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 13 2014 APRIL ANDROFERT
  • 14.
    Obesity in menat reproductive age ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 14 2014 APRIL ANDROFERT
  • 15.
    Total Testosterone (ng/dL)and Estradiol (pg/mL) Levels T/E2 Ratio Normal > 10 Zumoff et al. Metabolism 2003; Raman & Schlegel J Urol 2002 T/E2 <10 Aromatase Hyperactivity Aromatase inhibitors in obese- related oligozoospermia Anastrozole 1 mg q1d 60 days ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 15 2014 APRIL ANDROFERT
  • 16.
    Raman & Schlegel.J Urol. 2002 5.9 2.9 5.5 15.6 3.5 15.6 0 5 10 15 20 T/E ratio Ejaculate volume (mL) Sperm Count (million/mL) Anastrazole (1mg q1d for 3-6 months) in Oligozoospermia Pre-treatment Post-treatment Aromatase Inhibitors for Obesity-related Male Infertility ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 16 2014 APRIL ANDROFERT
  • 17.
    Who benefit frommedical Tx? Estradiol levels FSH & LH levels Total Testosterone levels <300ng/ dL Normal/ Elevated T/E ratio <10 <1.2 mUI/ mL Hypogonadism category T/E ratio >10 (nl) Hypo- hypo Aromatase hyperactivity Pure Treatment ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 17 2014 APRIL ANDROFERT
  • 18.
    Pure hypogonadism ART Candidates Severeoligozoospermia Non-obstructive azoospermia Options Anti-estrogens u-hCG/rec-hCG ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 18 2014 APRIL ANDROFERT
  • 19.
    Ramasamy et al.,J Urol. 2009 Ø  68 men with non-mosaic KS Ø  Non-obstructive azoospermia and hypogonadism Ø  ART candidates Ø  Medication to boost testosterone production: Aromatase inhibitor, hCG, anti-estrogens (2-3 months) Ø  Micro-TESE as SR method Ø  Positive response: increase in TT >100 ng/dL from baseline levels 72 55 Sperm Retrieval Rate (%) Positive response P  =  0.03   Medication before sperm retrieval in Klinefelter syndrome men (47,XXY) ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 19 2014 APRIL ANDROFERT
  • 20.
    51   51   Sperm retrieval rate (%) Positive response (n=252) No response (n=55) Ø  Case series (n=307): unselected group of men with testicular failure and low testosterone levels (300 nd/dL) Ø  Micro-TESE Ø  Medication to boost testosterone production: Aromatase inhibitor, hCG, anti-estrogens (min. 2-3 months) Ø  Positive response: posttreatment TT >250 ng/dL Medication prior to SR in unselected men with NOA Ramasamy et al., J Urol. 2011 ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 20 2014 APRIL ANDROFERT
  • 21.
    800   Before Clomiphene After 90d; 25mg/d DaRos CT, Averbeck MA Int Braz J Urol 2012 Anti-estrogens in Hypogonadism 1000   1200   1400   600   400   200   0   ng/dL Upper Limit Lower Limit Lower Sperm Counts ITT levels fall Normal Testosterone Levels Negative central feedback ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 21 2014 APRIL ANDROFERT
  • 22.
    Medical Tx -Key Messages (1) Empirical medication for idiopathic oligozoospermia not recommended Infertile males with hypogonadism (TT<300) candidates for Tx hCG is the treatment of choice for adult-onset hypogonadotropic hyponadism ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 22 2014 APRIL ANDROFERT
  • 23.
    Medical Tx -Key Messages (2) Aromatase inhibitors helpful for overweight/obese men with aromatase hyperactivity (T/E<10) and oligozoospermia hCG/anti-estrogens helpful to boost testosterone production (sperm production?) in selected ART candidates Minimum Tx duration 8 weeks; monitor TT levels regularly to dose titration ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 23 2014 APRIL ANDROFERT
  • 24.
    Lecture  Outline   Overview Empiric Tx of idiopathic oligozoospermia Specific Tx for subclinical MAGI Hormonal Tx for hypo-hypo Aromatase inhibitors in obese-related male infertility Antioxidants for oxidative-stress alleviation ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 24 2014 APRIL ANDROFERT
  • 25.
    Subclinical Male GenitalTract Infection ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 25 2014 APRIL ANDROFERT Urethritis, prostatitis AnN-­‐bacterial   properNes  (Zinc)  
  • 26.
    Yanushpolsky et al1996, Saleh & Agarwal 2002, Aziz et al 2004 Leukocytospermia >1.0 x 106 leukocytes per mL of semen marker of reproductive tract inflammation MacrophageNeutrophils Subclinical Male Genital Tract Infection (MAGI) ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 26 2014 APRIL ANDROFERT 25%   34%   39%   Normal Abnormal Abnl & Leukocytospermia % DNA Damage (SCSA)
  • 27.
    Seminal Leukocytes Endtz Test Simple diagnostic method Peroxidase-negative Peroxidase-positive Granulocytes (Neutrophils) substrate + H2O2 + semen Esteves et al. CLINICS 2011; 66:1-10. ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 27 2014 APRIL ANDROFERT
  • 28.
    •  Yanushpolsky etal, 1995; Erel et al., 1997 •  Branigan et al., 1995 Antibiotics •  Lackner et al., 2006 •  Gambera et al., 2007 Cicloxigenase-2 Inhibitors •  Oliva & Mutigner, 2006 Antihistamines •  Tremellen et al., 2007 •  Piombini et al., 2008 Antioxidants Treatment of Subclinical Male Genital Tract Infection and Associated Inflammatory Changes   ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 28 2014 APRIL ANDROFERT
  • 29.
    Subclinical Male GenitalTract Infection Azitromycin 1.0g single dose (couple)+ frequent ejaculation (every 2-3 days) + Antioxidants 42% leukocytospermia resolution (N=278; Androfert) ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 29 2014 APRIL ANDROFERT
  • 30.
    OxidaNve  Stress   30%-80%of infertile men have elevated markers of OS Agarwal et al., Urology 2006 An  emerging   explanaNon  for   several  cases  of   male  inferNlity   Oral Antioxidants ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 30 2014 APRIL ANDROFERT
  • 31.
    Chemical species withunpaired electron capable to oxidize lipids, proteins and nucleic acids: Superoxide anion (•O-2) Hydroxyl radical (•OH) Hydrogen peroxide (H2O2) Peroxyl radical (ROO•) Hypochlorite ion (OCl-) Generated from aerobic metabolism of sperm and leukocytes’ mitochondria Lampiao et al., 2012 Reactive Oxygen Species (ROS) Sperm and Seminal Plasma Antioxidants: Enzymatic (SOD, catalase, GPX): inactivate ROS by conversion into other substances Non-enzymatic (ascorbic acid, alpha-tocopherol, carnitine, etc.): neutralize ROS ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 31 2014 APRIL ANDROFERT
  • 32.
    Rationale of Oral Antioxidantsuse OA classified according to their mechanism of action: Catalytic: enhances the already present antioxidant enzymes (Glutathione, N- acetyl-cysteine). Scavenging: Water soluble: react with oxidants in the cytosol (Vitamin C) Lipid soluble: protect cell membrane from lipid peroxidation (Vitamin E) ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 32 2014 APRIL ANDROFERT
  • 33.
    Outcome No. studies Effect size (OR; 95% CI) Live birth 3 4.85 [1.92, 12.24] Pregnancy rate 15 4.18 [2.65, 6.59] DNA fragmentation 1 -13.80 [-17.50, -10.10] Miscarriage, sperm count, sperm motility 6-16 No effect Oral Antioxidants Showell MG et al. Cochrane Database Syst Rev 2011 ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 33 2014 APRIL ANDROFERT
  • 34.
    Oral Antioxidants •  Short-termuse appear to be safe •  Caution against indiscriminate use of high dosages for long periods Beneficial Kodama 1997 Dawson, 1992 Kessopoulou, 1995 Vezina, 1996 Vicari, 2001; 2002 Lenzi, 2003; 2004 Cavallini, 2004 Comhaire, 2005 Grecco 2005 Menezo 2007 Tremellen 2007 Piomboni 2008 Gil Villa 2009 No effect Giovenco, 1987 Moilanen, 1993 Iwanier, 1995 Rolf, 1999 Sigman, 2006 Detrimental long-term use and high doses; increased mortality in cancer population- based studies. Heinonen, 1994 Lonn, 2005 Bjelakovic, 2007 ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 34 2014 APRIL ANDROFERT
  • 35.
    How to useAntioxidant Therapy
 Ascorbic acid (Vit. C) α- tocopherol (Vit. E) Glutathione N-acetyl-cysteine Carnitine, Coenzyme Q10 Lycopene. Picnogenol Pentoxifylline. Selenium Shao-Fu-Zhu-Yu-Tang Astaxanthin Lepidium meyenii α -linolenic acid and lignans Folic acid, Zinc Select antioxidant formulation and dosage Testing for Leukocytes in Semen Differentiate between sperm and leukocyte source of ROS Varicocele Genital Infection Smoking Medication Drug abuse Systemic diseases Pollution Radiation Focus on identifying and controlling source of increased ROS ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 35 2014 APRIL ANDROFERT
  • 36.
    Oral Antioxidants How Iprescribe Vitamin C 500mg; Vitamin E 400 mg Folic acid 2 mg, Zinc 25 mg Selenium 26 mcg Minimum 2 months Old concept ~80 days New concept ~60 days From initiation of sperm production to ejaculation Misell LM et al. J Urol. 2006 Esteves & Agarwal. Novel concepts in male infertility. Int Braz J Urol 2011 ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 36 2014 APRIL ANDROFERT
  • 37.
    Asymptomatic leukocytospermia ismainly caused by urethritis ROS production increase with an increase in leukocyte numbers Antibiotic therapy is suggested, but effect on fertility is still unclear (GR-B) Medical Tx - Key Messages (3) ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 37 2014 APRIL ANDROFERT
  • 38.
    Oxidative stress impairssperm function and is a risk factor for male infertility (GR-A) OA supplementation for subfertile males improve the chances of live birth for couples undergoing ART (GR-A) Well-designed studies are needed to determine the best candidates for OA therapy and which formulation and dosages yield better results Medical Tx - Key Messages (4) ANDROFERT androfert.com.br ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION S ESTEVES, 38 2014 APRIL ANDROFERT
  • 39.
    Thank you Obrigado ‫شكرا‬